News
New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...
Scalp psoriasis poses unique challenges for people of color, including misdiagnosis, treatment access barriers, and lack of representation in medical education. Dr. Mona Shahriari, the senior editor ...
4don MSN
She was diagnosed with alopecia areata, an autoimmune condition that disrupts regular hair growth, at just 18 months old and ...
NOW the sun is out, your SPF should be too. Did you know we are recommended to use two shot glasses worth of suncream to cover our body? It might seem excessive, but no patch should be left ...
10d
Fashion Glamp on MSNThe Truth About Hair Growth Vitamins: What Experts Want You to KnowLong, lustrous hair is a universal desire, but the journey to achieve it often leads people to the vitamin aisle. Shelves are ...
Omni Medique is a specialist regenerative hair and scalp clinic providing non-surgical hair restoration and scalp treatment ...
Long, lustrous hair is a universal desire, leading many to seek hope in the vitamin aisle, where shelves are packed with bottles promising thicker and faster-growing hair. However, the burning ...
For many people with psoriasis, there are bad hair days — and then there are really bad hair days, complete with itchy, flaking scalp psoriasis that can look as icky as it feels. Scalp ...
1d
Verywell Health on MSNWhat Happens to Your Psoriasis When You Eat Manuka HoneyAlthough manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...
Roflumilast foam 0.3% applied once daily led to significantly greater clearance of scalp and body plaque psoriasis lesions and more rapid itch reduction than placebo over eight weeks.
Results showed 66% of patients treated with icotrokinra achieved an ss-IGA score of 0/1 and 77% achieved a sPGA-G score of 0/1, compared with 11% and 21% receiving placebo, respectively, at week 16.
Icotrokinra showed rapid efficacy among adults and adolescents with at least moderate psoriasis. Most participants with scalp psoriasis ... 23 receptors in people with moderate to severe plaque ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results